⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

Torrent Pharmaceuticals LimitedTORNTPHARM

TORNTPHARMβ‚Ή4,442.8β–Ό 2.83% today
Nifty Next 50

Torrent Pharmaceuticals is a branded-generics pharma company.

Key productsBranded generics in cardiac, CNS, GI and diabetology; some US generics.
GeographyIndia, US, Brazil, Germany.
CompetitorsSun Pharma, Cipla, Mankind.

AI-generated overview β€” verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 Β· tilt Neutral

Next corporate action

Dividend - Rs 9 Per Share

ex 2026-05-29

Competitive landscape β€” the read

vs mapped peers Β· 6M
Institutional money is backing ALKEM hardest (+β‚Ή1,013.7 Cr net). TORNTPHARM ranks #2 of 9 on flow (net buying +β‚Ή0 Cr). Filing momentum favours ZYDUSLIFE (+1). News & social buzz is most positive on DRREDDY.
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1ALKEM+β‚Ή1,013.7 Cr13β€”β€”-26
2TORNTPHARMThisβ€”β€”β€”β€”β€”β€”
3CIPLAβ€”β€”β€”β€”+1944
4DRREDDYβ€”β€”β€”β€”+2046
5SUNPHARMAβ€”β€”β€”β€”+1545
6LUPINβ€”β€”β€”β€”β€”β€”
7ZYDUSLIFEβ€”β€”1+1β€”β€”
8AUROPHARMAβ€”β€”β€”β€”β€”β€”
9MANKINDβ€”β€”β€”β€”β€”β€”

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline β€” TORNTPHARM day by day

  1. 2026-05-29ActionDividend - Rs 9 Per ShareDividend
  2. 2026-02-18ActionInterim Dividend - Rs 29 Per ShareDividend

Merged from deals, filings, corporate actions and news β€” newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

No scored filings for TORNTPHARM yet.

Bulk & block deals

No bulk/block deals for TORNTPHARM in this window.

News & chatter on TORNTPHARM

RSS News

0

No recent news.

Google News RSS β€” links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.